Crystal Structure of PKG I:cGMP Complex Reveals a cGMP-Mediated Dimeric Interface that Facilitates cGMP-Induced Activation

Cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG) is a key regulator of smooth muscle and vascular tone and represents an important drug target for treating hypertensive diseases and erectile dysfunction. Despite its importance, its activation mechanism is not fully understood. To...

Full description

Saved in:
Bibliographic Details
Published inStructure (London) Vol. 24; no. 5; pp. 710 - 720
Main Authors Kim, Jeong Joo, Lorenz, Robin, Arold, Stefan T., Reger, Albert S., Sankaran, Banumathi, Casteel, Darren E., Herberg, Friedrich W., Kim, Choel
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 03.05.2016
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG) is a key regulator of smooth muscle and vascular tone and represents an important drug target for treating hypertensive diseases and erectile dysfunction. Despite its importance, its activation mechanism is not fully understood. To understand the activation mechanism, we determined a 2.5 Å crystal structure of the PKG I regulatory (R) domain bound with cGMP, which represents the activated state. Although we used a monomeric domain for crystallization, the structure reveals that two R domains form a symmetric dimer where the cGMP bound at high-affinity pockets provide critical dimeric contacts. Small-angle X-ray scattering and mutagenesis support this dimer model, suggesting that the dimer interface modulates kinase activation. Finally, structural comparison with the homologous cyclic AMP-dependent protein kinase reveals that PKG is drastically different from protein kinase A in its active conformation, suggesting a novel activation mechanism for PKG. [Display omitted] •Structure of monomeric PKG I R reveals a new dimeric interface mediated by cGMP•Mutagenesis of the key interface residues reduces cGMP binding and activation•SAXS analysis of the PKG I R dimer supports the cGMP-mediated dimer model•The dimeric interface may acts as a “safety lock” to ensure kinase activation Kim et al. obtain the first crystal structure of the PKG I R domain bound with cGMP representing its activated state. It reveals a symmetric R dimer where cGMP molecules provide dimeric contacts. This R-R interaction prevents the high-affinity inhibitory interaction between R-C domain and sustains activation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
King Abdullah University of Science and Technology (KAUST)
European Union (EU)
AC02-05CH11231; R01 GM090161; R21 HL111953; 241481
USDOE Office of Science (SC), Basic Energy Sciences (BES)
National Institutes of Health (NIH)
Current address:Patheon Biologics-STL, St. Louis, Missouri 63134, United States of America
ISSN:0969-2126
1878-4186
DOI:10.1016/j.str.2016.03.009